Trademark: 79307453
Word
HANHUI
Status
Registered
Status Code
700
Status Date
Tuesday, June 28, 2022
Serial Number
79307453
Registration Number
6770020
Registration Date
Tuesday, June 28, 2022
Mark Type
4000
Filing Date
Saturday, January 30, 2021
Published for Opposition
Tuesday, April 12, 2022

Trademark Owner History
Hanhui Pharmaceuticals Co., Ltd. - Original Registrant

Classifications
5 Pharmaceutical preparations for use in chemotherapy, radiotherapy, endocrine therapy, anesthesia; Pharmaceutical preparations for supplementing vitamins and nutrition, namely, dietary and nutritional supplements; Pharmaceutical preparations for anti-infection and antiviral purposes; Pharmaceutical preparations for improving lactation functions; Pharmaceutical preparations for treating hematological diseases, namely, anemia, leucocyte disorders, blood clots; Pharmaceutical preparations for treating cardiovascular and cerebrovascular diseases, namely, blood lipid disorder, blood pressure disorder, arrhythmia, cardiac insufficiency, angina pectoris, myocardial infarction; Pharmaceutical preparations for treating respiratory system diseases, namely, phlegm, cough, asthma; Pharmaceutical preparations for treating digestive system diseases and disorders, namely, peptic ulcer, diarrhea; Pharmaceutical preparations for treating central nervous diseases and disorders, namely, fever and pain, gout, epilepsy, Parkinsonian syndrome, psychotic disorders, depression, anxiety, mania; Pharmaceutical preparations for treating geriatric diseases, namely, hyperosteogeny, prostatic hyperplasia, senile cataract; Pharmaceutical preparations for treating genitourinary system diseases, endocrine and metabolic system diseases and disorders, allergies, immune system diseases and disorders, liver and gall diseases, Alzheimer's diseases, skin diseases and disorders, obstetric and gynecological diseases and disorders, diseases with eye, ear, nose, mouth, oral cavity, and throat; Chemical preparations for pharmaceutical and medical purposes, namely, antineoplastic drugs, antibiotics, anti-infectives, vitamins and nutritional supplements, anesthetics, and those for treating hematological system diseases, cardiovascular and cerebrovascular diseases, endocrine and metabolic diseases and disorders, respiratory system diseases, digestive system diseases and disorders, central nervous system diseases and disorders, dermatological diseases, obstetric and gynecological diseases and disorders, ophthalmology and otorhinolaryngology diseases, and geriatric diseases; Analgesics; Medicines for humans, namely, antineoplastic drugs, anti-infectives, antibiotics, anesthetics, vitamin and nutritional supplements, and medicines for the treatment of allergy, cardiovascular and cerebrovascular diseases, dermatological diseases, geriatric diseases, and diseases with hematological system, genitourinary system, endocrine and metabolic system, immune system, respiratory system, digestive system, central nervous system, obstetrics and gynecology system, eye, ear, mouth, and throat; Sedatives; Tranquillizers; Biological preparations for medical purposes, namely, vaccines, antineoplastic preparations, antitoxin, and antisera; Antibiotics; Injectable pharmaceuticals, namely, antineoplastic drugs, anti-infectives, antibiotics, anesthetics, vitamin and nutritional supplements, and those for the treatment of allergy, cardiovascular and cerebrovascular diseases, dermatological diseases, geriatric diseases, ophthalmology and otorhinolaryngology diseases, and diseases with hematological system, genitourinary system, endocrine and metabolic system, immune system, respiratory system, digestive system, central nervous system, obstetrics and gynecology system; Tablets, namely, antineoplastic drugs, anti-infectives, antibiotics, anesthetics, vitamin and nutritional supplements, and tablets for the treatment of allergy, cardiovascular and cerebrovascular diseases, dermatological diseases, geriatric diseases, ophthalmology and otorhinolaryngology diseases, and diseases with hematological system, genitourinary system, endocrine and metabolic system, immune system, respiratory system, digestive system, central nervous system, obstetrics and gynecology system; Bulk medicines, namely, antineoplastic drugs, anti-infectives, antibiotics, anesthetics, vitamin and nutritional supplements, and medicines for the treatment of allergy, cardiovascular and cerebrovascular diseases, dermatological diseases, geriatric diseases, ophthalmology and otorhinolaryngology diseases, and diseases with hematological system, genitourinary system, endocrine and metabolic system, immune system, respiratory system, digestive system, central nervous system, obstetrics and gynecology system; Biochemical medicines, namely, antineoplastic drugs, anti-infectives, antibiotics, and medicines for the treatment of allergy, cardiovascular and cerebrovascular diseases, and diseases with hematological system, genitourinary system, endocrine and metabolic system, immune system, respiratory system, digestive system, and central nervous system; Blood for medical purposes; Herbal tinctures for medical purposes; Diagnostic preparations for medical purposes; Chemical reagents for medical or veterinary purposes; Radium for medical purposes; Radioactive substances for medical purposes; Isotopes for medical purposes; Radioactive medicines for medical imaging and the treatment of tumor and thyroid diseases; Oxygen for medical purposes; Chemical conductors for electrocardiograph electrodes; Semen for artificial insemination; Disinfectants for hygiene purposes; Disinfectants; Solutions for contact lenses; Contact lens cleaning preparations; Media for bacteriological cultures; Bouillons for bacteriological cultures; Bacteriological culture mediums; Nutritive substances for microorganisms for medical purposes; Cultures of microorganisms for medical and veterinary use; Disinfectant wipes; Wadding for medical purposes; Food for babies

Trademark Events
Apr 9, 2023
New Representative At Ib Received
Nov 1, 2022
Final Decision Transaction Processed By Ib
Oct 6, 2022
Final Disposition Notice Sent To Ib
Oct 6, 2022
Final Disposition Processed
Sep 28, 2022
Final Disposition Notice Created, To Be Sent To Ib
Aug 21, 2022
New Representative At Ib Received
Jun 28, 2022
Notice Of Registration Confirmation Emailed
Jun 28, 2022
Registered-Principal Register
Apr 12, 2022
Official Gazette Publication Confirmation E-Mailed
Apr 12, 2022
Published For Opposition
Mar 23, 2022
Notification Of Notice Of Publication E-Mailed
Mar 8, 2022
Approved For Pub - Principal Register
Mar 8, 2022
Examiner's Amendment Entered
Mar 8, 2022
Notification Of Examiners Amendment E-Mailed
Mar 8, 2022
Examiners Amendment E-Mailed
Mar 8, 2022
Examiners Amendment -Written
Feb 3, 2022
Teas/Email Correspondence Entered
Feb 2, 2022
Correspondence Received In Law Office
Feb 2, 2022
Teas Response To Office Action Received
Jan 28, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Jan 28, 2022
Teas Change Of Correspondence Received
Jan 28, 2022
Teas Change Of Domestic Representatives Address
Jan 28, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 28, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 28, 2022
Teas Change Of Owner Address Received
Sep 20, 2021
Refusal Processed By Ib
Aug 28, 2021
Non-Final Action Mailed - Refusal Sent To Ib
Aug 28, 2021
Refusal Processed By Mpu
Aug 24, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Aug 23, 2021
Non-Final Action Written
Aug 19, 2021
Assigned To Examiner
Mar 30, 2021
Application Filing Receipt Mailed
Mar 26, 2021
New Application Office Supplied Data Entered
Mar 25, 2021
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24